Overview

  • Product name
    PI 103
  • Description
    Potent cell-permeable PI3K inhibitor
  • Biological description
    Potent, cell-permeable ATP-competitive PI3K inhibitor (IC50 values are 2, 8, 20, 26, 48, 83, 88 and 150 nM for DNA-PK, p110α, mTORC1, PI3-KC2β, p110δ, mTORC2, p110β, and p110γ, respectively). Shows antiproliferative effects against cancer cell lines. Shows antitumor effects in vivo.
  • Purity
    > 95%

Properties

    References for PI 103 (ab141361)

    This product has been referenced in:
    • Duan Q  et al. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning. J Mol Cell Cardiol 80C:114-125 (2015). Read more (PubMed: 25575882) »
    • Gedaly R  et al. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Anticancer Res 30:4951-8 (2010). Read more (PubMed: 21187475) »
    • Park S  et al. PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia 22:1698-706 (2008). Read more (PubMed: 18548104) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab141361.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

    Sign up